Detalhe da pesquisa
1.
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment.
Future Oncol
; 19(8): 559-573, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070653
2.
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.
N Engl J Med
; 379(20): 1926-1936, 2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345905
3.
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.
Clin Chem
; 65(11): 1405-1413, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551314
4.
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 373(3): 209-19, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26030518
5.
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 373(17): 1672-3, 2015 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26488700
6.
Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men.
Clin Pharmacol Ther
; 111(1): 302-309, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668577
7.
Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.
PLoS One
; 15(4): e0227256, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315295
8.
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer.
Clin Cancer Res
; 26(1): 110-121, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527167
9.
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
J Natl Cancer Inst
; 111(4): 419-430, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30032196
10.
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
J Clin Oncol
; 37(14): 1169-1178, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807234
11.
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.
J Glob Oncol
; 5: 1-19, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125276
12.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523750
13.
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.
Cancer Discov
; 8(11): 1390-1403, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206110